Thursday, May 8, 2025

Enhanced CAR T cell therapy offers new strategy for lymphoma

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

from Top Health News -- ScienceDaily https://ift.tt/pto7C5h
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A “ghost” great white shark just reignited a 160-year Mediterranean mystery

The capture of a juvenile great white shark in Spain has provided fresh evidence that the Mediterranean's elusive "ghost" popu...